These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Antiemetic therapy for non-anthracycline and cyclophosphamide moderately emetogenic chemotherapy. Inui N Med Oncol; 2017 May; 34(5):77. PubMed ID: 28365889 [TBL] [Abstract][Full Text] [Related]
6. Advances in the management of nausea and vomiting induced by non-cisplatin containing chemotherapeutic regimens. Grunberg SM Blood Rev; 1989 Dec; 3(4):216-21. PubMed ID: 2692744 [TBL] [Abstract][Full Text] [Related]
7. [New developments in the treatment of nausea and vomiting caused by chemotherapy]. de Wit R; van Alphen MM Ned Tijdschr Geneeskd; 2003 Apr; 147(15):690-4. PubMed ID: 12722531 [TBL] [Abstract][Full Text] [Related]
8. Reviewing current and emerging antiemetics for chemotherapy-induced nausea and vomiting prophylaxis. Natale JJ Hosp Pract (1995); 2015; 43(4):226-34. PubMed ID: 26308912 [TBL] [Abstract][Full Text] [Related]
9. Acute and delayed nausea and emesis control in pediatric oncology patients. Holdsworth MT; Raisch DW; Frost J Cancer; 2006 Feb; 106(4):931-40. PubMed ID: 16404740 [TBL] [Abstract][Full Text] [Related]
10. Neurokinin-1 receptor antagonists for chemotherapy-induced nausea and vomiting: a systematic review. dos Santos LV; Souza FH; Brunetto AT; Sasse AD; da Silveira Nogueira Lima JP J Natl Cancer Inst; 2012 Sep; 104(17):1280-92. PubMed ID: 22911671 [TBL] [Abstract][Full Text] [Related]
11. [Research on antiemetics: an Italian model of success]. Roila F Tumori; 1998; 84(1 Suppl):S3-11. PubMed ID: 9617377 [TBL] [Abstract][Full Text] [Related]
12. [Effectiveness and tolerance of Navoban (5HT3-receptor antagonist tropisetron) in prevention of cytostatic drug-induced nausea and vomiting in patients with breast carcinomas and gynecological malignancies]. Regidor PA; Nelken B; Regidor M; Bier U; Oberhoff C; Schindler AE Zentralbl Gynakol; 1996; 118(3):148-53. PubMed ID: 8900604 [TBL] [Abstract][Full Text] [Related]
13. [Optimal control by ondansetron of acute and prolonged emesis induced by chemotherapy without cisplatin]. Harousseau JL Bull Cancer; 1996 Jan; 83(1):71-76. PubMed ID: 8672859 [TBL] [Abstract][Full Text] [Related]
14. [The antiemetic action of tropisetron (Navoban) in the cytostatic treatment of neoplastic diseases]. Buiuc AI; Găleşanu MR Rev Med Chir Soc Med Nat Iasi; 1996; 100(3-4):160-4. PubMed ID: 9455457 [TBL] [Abstract][Full Text] [Related]
15. Optimal selection of antiemetics in children receiving cancer chemotherapy. Roila F; Aapro M; Stewart A Support Care Cancer; 1998 May; 6(3):215-20. PubMed ID: 9629872 [TBL] [Abstract][Full Text] [Related]
16. 2016 Updated MASCC/ESMO Consensus Recommendations: Controlling nausea and vomiting with chemotherapy of low or minimal emetic potential. Olver I; Ruhlmann CH; Jahn F; Schwartzberg L; Rapoport B; Rittenberg CN; Clark-Snow R Support Care Cancer; 2017 Jan; 25(1):297-301. PubMed ID: 27572335 [TBL] [Abstract][Full Text] [Related]
17. A review of olanzapine as an antiemetic in chemotherapy-induced nausea and vomiting and in palliative care patients. Fonte C; Fatigoni S; Roila F Crit Rev Oncol Hematol; 2015 Aug; 95(2):214-21. PubMed ID: 25779971 [TBL] [Abstract][Full Text] [Related]
18. Reducing chemotherapy-induced nausea and vomiting. Current perspectives and future possibilities. Del Favero A; Roila F; Tonato M Drug Saf; 1993 Dec; 9(6):410-28. PubMed ID: 7510495 [TBL] [Abstract][Full Text] [Related]
19. A randomized, multicenter study comparing the efficacy and tolerability of tropisetron, a new 5-HT3 receptor antagonist, with a metoclopramide-containing antiemetic cocktail in the prevention of cisplatin-induced emesis. Sorbe BG; Högberg T; Glimelius B; Schmidt M; Wernstedt L; Hansen O; Sörensen BT; Räisänen I; van Oosterom AT; de Bruijn KM Cancer; 1994 Jan; 73(2):445-54. PubMed ID: 8293412 [TBL] [Abstract][Full Text] [Related]
20. 5-HT3-receptor antagonists: a review of pharmacology and clinical efficacy. Cunningham RS Oncol Nurs Forum; 1997 Aug; 24(7 Suppl):33-40. PubMed ID: 9282379 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]